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Background:  Downsized  devices  for less  invasive  endovascular  treatment  are  gaining  more  attention.
Case  report:  An 82-year-old  woman  was  admitted  to  our  hospital  with  pain  and  swelling  in  left  lower
extremity.  Ultrasonography  showed  much  thrombus  at the  left  common  femoral,  superﬁcial  femoral,
and  popliteal  veins,  conﬁrming  a diagnosis  of  acute deep  vein  thrombosis  (DVT).  For lack  of therapeu-
tic  effect  of  systemically  administered  anticoagulative  and  thrombolytic  agents,  we  performed  catheter
intervention  against  DVT.  After insertion  of a 4.5  French  guiding  sheath  (Parent  Plus, Medikit,  Tokyo,
Japan)  into  left popliteal  vein,  venography  showed  a total  occlusion  of  the  common  femoral  vein.  Even
after  thrombectomy  by aspiration  catheter,  balloon  dilation,  and  catheter-induced  thrombolysis,  severe
stenosis  at the  proximal  site  of  the  left  common  iliac  vein  remained.  After  conﬁrming  the  presence  of
iliac  vein  compression  syndrome  (IVCS)  by  intravascular  ultrasound  imaging,  we  successfully  implanted
a  Zilver® stent (Cook  Inc., Bloomington,  IN, USA)  in  the  common-external  iliac  vein  through  a  4.5 French
guiding  sheath,  leading  to  an optimal  venous-return  ﬂow.
Conclusions:  The  present  case  suggests  that  in  addition  to  thrombus  aspiration,  Zilver  stent  implantation
using  a 4.5  French  guiding  sheath  has the  potential  to serve  as a  minimally  invasive  strategy  for  the
treatment  of  IVCS  complicated  with  iliofemoral  DVT.
<Learning  objective:  During  the interventional  treatment  of  deep  vein  thrombosis,  we should  pay  atten-
tion  to  procedure-related  venous  valve  dysfunction  in addition  to  bleeding  complications  and  pulmonary
embolism.  From  the  point  of  view,  downsized  catheter  devices  might  have  some  advantage  with lesser
prevalence  of  those  complications.>
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Implantation of self-expandable stents, such as Wallstent®
Boston Scientiﬁc, Natick, MA,  USA) and Smart® stent (Cordis,
ridgewater, NJ, USA), has been a mainstay of the interventional
reatment of iliac vein compression syndrome (IVCS) in West-
rn countries [1–3]. Despite the clinical efﬁcacy of those stents,
owever, it is necessary for stent delivery to employ a vascu-
ar guiding sheath with larger than 6 French size for vascular
ccess, and besides bleeding complications at the vascular access
ite, careful attention should be paid to compromised deep vein
hrombosis (DVT) concomitant with venous valve dysfunction. We
escribe our experience with an IVCS/DVT case, in which a nitinol
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self-expandable stent (Zilver® stent, Cook Inc., Bloomington, IN,
USA) could be successfully implanted using a 4.5 French vascular
guiding sheath (Parent Plus, Medikit, Tokyo, Japan).
Case report
An 82-year-old female was  admitted to our hospital with pain,
swelling, and tenderness in left lower extremity for the previ-
ous 24 h. She had no remarkable past history, but had walking
disturbance due to severe lumbago of unknown etiology before
admission. Routine blood test at admission showed elevation of
D-dimer (21.98 mg/L), and low-grade renal dysfunction (creati-
nine 1.22 mg/dL) with normal values of creatine phosphokinase
and C-reactive protein. Protein C activity and protein S activ-
ity were within the normal range. Subsequent ultrasonography
showed much thrombus at the left common femoral, superﬁcial
vier Ltd. All rights reserved.
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lig. 1. Venography in the prone position. (A) A total occlusion with a ﬁlling defect
eft  common iliac vein (white arrowhead). (C) An optimal venographic result after i
emoral, and popliteal veins without color ﬂow signal, conﬁrming a
iagnosis of acute DVT. After implantation of inferior vena cava
IVC) ﬁlter (TrapEase, Cordis), she began therapy with peripheral
ntravenous infusion of unfractionated heparin and urokinase in
ddition to oral warfarin. Even after the anticoagulation therapy
nd the thrombolysis therapy for 5 days, her condition in the left
ower extremity did not improve. Thus, we decided to perform
nterventional treatment against DVT in her left lower extremity.In the prone position, after conﬁrming the patency of the left
opliteal vein by ultrasonography, vascular access was  obtained
y ultrasonography-guided puncture of the left popliteal vein,
nd 4.5 French 55 cm guiding sheath was introduced. Ascending
ig. 2. Intravascular ultrasound (IVUS) images (panels B–F) just before stent implantation
liac  vein. (C) A signal ascribed to inferior vena cava ﬁlter (white arrowhead) at the term
ompression at the proximal left common iliac vein. (E) Symmetrically thickened vessel w
eft  external iliac vein. left common femoral vein. (B) Severe residual stenosis at the proximal site of the
tation of a nitinol self-expandable stent 10/80 mm (Zilver®) in the left iliac vein.
venography showed a few clots of thrombus in the superﬁcial
femoral vein and total occlusion in the common femoral vein
(Fig. 1A). Even after breaking the thrombus in the iliac vein by
rotating pigtail catheter and aspirating much thrombus using a
thrombectomy catheter (Dio; Goodman, Nagoya, Japan), a total
occlusion in the common iliac vein remained. Using the aspira-
tion catheter (Dio) and a 0.035 in. J-type wire (Radifocus, Terumo,
Tokyo, Japan), we crossed the iliac vein occlusion with some dif-
ﬁculties. Then, we  exchanged the 0.035 in. wire with a 0.014 in.
wire (Spindle XS 0.7 300 cm,  Asahi Intecc, Aichi, Japan) via the
aspiration catheter, subsequently dilated the iliac vein with bal-
loon catheter 6.0/120 mm  (Savvy Long, Cordis), and directly infused
. (A) Fluoroscopy in the prone position. (B) Normal appearance at the proximal right
inal inferior vena cava. (D) A wedge-like position of IVUS catheter due to external
all at the left common iliac vein distal to the culprit. (F) Residual thrombus at the
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aig. 3. Intravascular ultrasound images (panels B–D) immediately after stent impla
iew  of ﬂuoroscopy in the prone position. (B) Optimal expansion of the stent at th
ompression at the culprit. (D) Optimal expansion of the stent at the left common i
20,000 units of urokinase through pulse spray catheter (Mistique,
ordis). Even after those procedures, severe persistent stenosis at
he proximal site of the left common iliac vein was  observed, sug-
esting the presence of IVCS (Fig. 1B). Subsequent intravascular
ltrasound imaging (IVUS) (Eagle Eye, Volcano, San Diego, CA, USA)
epicted a pulsatile external compression in the left common iliac
ein close to the IVC (Fig. 2D) as well as symmetrically thickened
essel wall with hyperechoic intensity (Fig. 2E) and residual throm-
us in the left external iliac vein (Fig. 2F), conﬁrming the diagnosis
f IVCS concomitant with DVT. In order to prevent re-occlusion
f the left iliac vein and relieve her leg symptoms, we  released
 nitinol self-expandable stent 10/80 mm (Zilver) in the segment
etween the just proximal left common iliac vein and the left exter-
al iliac vein. Right anterior view of ﬂuoroscopy detected focal
nderexpansion of the stent in the culprit site (Fig. 3A), and repeat
VUS showed a suboptimal dilation due to pulsatile external com-
ression in the culprit (Fig. 3C). Additional dilation with balloon
atheter 6.0/120 mm (Savvy Long) did not improve the stent expan-
ion deﬁnitely. Final venography showed good venous-return ﬂow
ithout ﬂow delay (Fig. 1C). Hemostasis was easily achieved imme-
iately after the procedure. In addition to anticoagulant therapy
ith warfarin, antiplatelet therapy with aspirin was added after
he interventional treatment. Left lower extremity swelling dra-
atically improved and completely disappeared 7 days after the
rocedure. She has been convalescent on an outpatient basis, taking
 mg/day of warfarin and 100 mg/day of aspirin.
iscussion
The present case report suggests that in addition to thrombec-
omy by aspiration catheter, Zilver stent implantation using
.5 French guiding sheath could be an alternative minimally inva-
ive interventional treatment for IVCS complicated with DVT.
iniaturized devices for less invasive catheter intervention in aariety of ﬁelds including coronary artery, peripheral artery, and
enal artery are gaining more attention. Even in venous inter-
ention, smaller devices have some possible advantages. Vascular
ccess with a smaller-sized vascular sheath or guiding sheathn. (A) A focal underexpansion of the stent (white arrowhead) in the right anterior
t proximal right iliac vein. (C) An asymmetric expansion due to pulsatile external
in distal to the culprit.
might have less prevalence of bleeding complications at the access
site under anticoagulative and thrombolytic therapy, procedure-
induced venous valve injury, and possibly procedure-provoked
pulmonary embolism. In contrast, downsized catheter device might
have the disadvantage of difﬁculty in aspirating large thrombus as
well as of limitations of available interventional devices.
Under conventional anticoagulation therapy alone, iliofemoral
DVT with/without IVCS frequently elicits symptoms of postthrom-
botic syndrome (PTS), such as persistent pain, swelling, skin
changes, and ulceration in the affected-side lower extremity.
Accumulating studies and case reports have shown usefulness
of early interventional treatment of venous outﬂow obstruction
via thrombus aspiration, catheter-directed thrombolysis, balloon
angioplasty, and stenting for reducing PTS [4–7]. However, def-
inite evidence supporting superiority of endovascular therapy
over anticoagulation therapy alone in the treatment of acute
DVT is still lacking. A multicenter randomized trial, the ATTRACT
study, is currently ongoing to examine whether pharmacome-
chanical catheter-directed thrombolysis is superior to standard
anticoagulation therapy alone in preventing PTS among proximal
(iliofemoral) DVT patients during 24-month follow-up [8].  Results
of the ATTRACT Study could encourage cardiovascular interven-
tionalists to treat proximal DVT in the near future. In contrast,
although surgical thrombectomy using Fogarty catheter could also
be an alternative treatment for proximal DVT, surgical thrombec-
tomy had relatively high prevalence of repeat thrombotic occlusion
and procedure-related venous valve dysfunction [9].
Frequency of IVCS ranges from 18% to 49% among patients with
left-sided lower extremity DVT [4].  Endovascular treatment includ-
ing stent placement against IVCS complicated with DVT  has been
reported to be feasible and effective with 79–100% and 80% primary
patency rates at 1–2 years and 4 years, respectively [1–4,10],  while
endovascular treatment without stent implantation has high 73%
recurrence rate [11]. Thus, iliac vein stenting is indispensable for
endovascular treatment of IVCS; however, nowadays in Japan it is
still “off-label use” to implant stents in the treatment of IVCS. In the
present case with the residual stent-underexpansion, elastic stock-
ing usage could be effective in the prevention of DVT recurrence,
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acute extensive iliofemoral deep venous thrombosis caused by May-Thurner
syndrome. J Vasc Interv Radiol 2000;11:1297–302.56 S. Hashimoto et al. / Journal of
nd up-sized balloon dilation as well as another stent implantation
t the residual lesion inside the old stent might be necessary in the
ondition with DVT recurrence.
onclusion
The present case suggests that in addition to thrombectomy by
spiration catheter, Zilver stent implantation using a 4.5 French
uiding sheath has the potential to serve as a minimally invasive
trategy for the treatment of IVCS complicated with iliofemoral
VT.
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